ArticleHematological oncology2025

Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.

Massimo Breccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.